Pfizer, Inc.: updates and filings

PFENYSEHealthcare · Pharmaceutical Preparations

Price

$28.18

November 18, 2026Market cap $160B

What Ploutos Investor adds for Pfizer

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 79 daysAround Feb 5, 2027 · for Q4 2026

last Nov 3, 2026next Feb 5, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 26, 2026 latest annualNov 3, 2026 latest quarterly
  • Nov 12, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Nov 3, 2026Officer or director change
    Form8-K
  • Nov 3, 2026Quarterly reportfor the period to Sep 27, 2026
    Form10-Q
  • Nov 3, 2026Results of operations
    Form8-K
  • Aug 31, 2026Filing
    FormN-PX
  • Aug 13, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Aug 4, 2026Quarterly reportfor the period to Jun 28, 2026
    Form10-Q
  • Aug 4, 2026Results of operations
    Form8-K
  • Jun 18, 2026Regulation FD disclosure
    Form8-K
  • Jun 18, 2026Officer or director change
    Form8-K
  • Jun 16, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • Jun 16, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 12, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • May 5, 2026Shares registered for employees
    FormS-8
  • May 5, 2026Quarterly reportfor the period to Mar 29, 2026
    Form10-Q
  • May 5, 2026Results of operations
    Form8-K
  • May 1, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 27, 2026Shareholder vote
    Form8-K
  • Mar 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 12, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Mar 12, 2026Additional annual meeting material
    FormDEFA14A
  • Mar 12, 2026Annual meeting proxy statement
    FormDEF 14A
  • Feb 26, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 12, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Feb 3, 2026Results of operations
    Form8-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Mar 18, 1994: every report, 8-K, meeting and letter. Of its other filings (1,271 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 68.

The full analysis

What do Pfizer's filings show?

The filings are where every one of Pfizer's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.